Infusion related reactions to anti-TNF@a chimeric monoclonal antibody, REMICADE^T^M, can be abrogated by premedication: One site's experience

MLA

Petroniene, R., et al. “Infusion Related Reactions to Anti-TNF@a Chimeric Monoclonal Antibody, REMICADE^T^M, Can Be Abrogated by Premedication: One Site’s Experience.” Gastroenterology, vol. 120, no. 5, Number 5 Supplement 1, Apr. 2001, p. 620. EBSCOhost, https://doi.org/10.1016/S0016-5085(01)83082-1.

APA

Petroniene, R., Baker, J. P., Crosara-Winter, B. C. R., Ottaway, C. A., Moore, T. L., Connon, J. J., & Jeejeebhoy, K. N. (2001). Infusion related reactions to anti-TNF@a chimeric monoclonal antibody, REMICADE^T^M, can be abrogated by premedication: One site’s experience. Gastroenterology, 120(5, Number 5 Supplement 1), 620. https://doi.org/10.1016/S0016-5085(01)83082-1

Chicago

Petroniene, R., J.P. Baker, B.C.R. Crosara-Winter, C.A. Ottaway, T.L. Moore, J.J. Connon, and K.N. Jeejeebhoy. 2001. “Infusion Related Reactions to Anti-TNF@a Chimeric Monoclonal Antibody, REMICADE^T^M, Can Be Abrogated by Premedication: One Site’s Experience.” Gastroenterology 120 (5, Number 5 Supplement 1): 620. doi:10.1016/S0016-5085(01)83082-1.